The Latest

FDA Says U.S. Approved India Psychotropic Drug Maker Has Dirty Lab

The FDA is returning to a normal overseas inspection workload. What they are finding is not pretty.

FDA Again Allows Unapproved Chinese Chemotherapy Drugs into the U.S.

The FDA approved Qilu Pharmaceuticals from Shandong, China, to sell the generic oncology drug cisplatin along with carboplatin.

Generic Drugs Maker Intas Pharmaceuticals Keeps Failing Inspections

Intas received 16 “observations” on their Form 483 inspection report.

At India Drug Maker Aurobindo Lab, FDA Finds “Deficient” Manufacturing Equipment

America’s drug supply is increasingly reliant on companies who continually get failing grades from the Food & Drug Administration.

FDA Allows Uninspected China Lab to Sell Cancer Drugs in the US

“We can’t risk patients' lives by giving them potentially bad drugs from unapproved manufacturers."

Notorious India Drug Maker Intas Pharmaceuticals Gets FDA Import Alert, But Allowed to Export to US

An import alert means the lab’s products are off limits to the U.S. until corrections are made to its manufacturing processes.

FDA Considers Allowing Cancer Drug Imports from Unapproved Foreign Manufacturers

Shocking Decision Risks Patients Lives Battling Cancer WASHINGTON — Americans for Safe Drugs, a campaign led by the Coalition for a...

India-Based Contract Drug Manufacturer Astral SteriTech Recalls Medications

The recall was being initiated because of failures in environmental monitoring of the facility where the drugs are made.